Larvol Delta - Cantargia-Announces-AACR-2026-Presentation-of-Study-Design-and-Supportive-PreClinical-Data-for-InvestigatorInitiated-Nadunolimab-Study-in-MSS-CRC

nadunolimab (CAN04) - Cantargia

https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/cantargia-announces-aacr-2026-presentation-of-study-design-and-suppor-1158747

Apr 17, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next